Amid the ongoing opioid crisis, Purdue Pharma has proposed a new bankruptcy plan. The pharmaceutical giant is offering a settlement of at least $7.4 billion to address its role in the crisis.
Purdue Pharma Says It Will Transform Into ‘Public Benefit Company,’ As It Files For Bankruptcy — Proposes $7.4 Billion Settlement In Opioid Case
